From: Serum lnc34a is a potential prediction biomarker for bone metastasis in hepatocellular carcinoma patients
Variable
Bone metastasis
HR (95% CI)
P
Vascular invasion (no versus yes)
6.625(2.291–19.157)
< 0.001
BCLC stage (0-A versus B-C)
3.910(1.244–12.287)
0.020
Lnc34a (low versus high)
3.883(1.107–13.629)
0.034